New Delhi, Aug. 20 -- Confounding clinical presentation, complex disease pathways, a disparate healthcare ecosystem and fragmented diagnostics pose some of healthcare's most difficult diagnostic challenges. These are not unique to India but plague the world with devastating consequences. Poor access to near point of care advanced solutions in infectious diseases, delays associated in a hub and spoke model of testing through centralised laboratories and complexity of cascading diagnostics in infectious diseases continue to challenge health systems across the world.
HaystackAnalytics identified a critical gap in this landscape - advanced clinical-grade diagnostics existed but were inaccessible.
For full video, visit - https://youtu.be/MQ5uxpI6sZA?si=mZqnvq7JqLO0vb5S
Through its expanding network of Genomic Centres of Excellence (GCEs), the company has demonstrated the power of distributive genomics in infectious disease diagnostics in India, a model where advanced clinical grade genomics based diagnostics are not confined to a handful of specialised centres, but are embedded closer to the patients, hospitals, and clinicians who need it the most.
Over the next 12 months, HaystackAnalytics plans to scale the network to 100 centres across India, thus working towards a future of rewriting the diagnostic playbook in infectious disease diagnostics.
At that scale, genomic infection diagnostics could become accessible across a far broader healthcare footprint. Hospitals that previously depended on distant specialised facilities or conventional approaches could gain access to advanced sequencing capabilities within their own diagnostic ecosystems, helping clinicians investigate complex infections closer to where patients are being treated.
This Independence Day, that ambition is brought to life by the people behind it. The company celebrates the Indian scientists and institutions building diagnostic capability at home, with the potential to address challenges shared globally.
HaystackAnalytics envisions a future where Indian genomics does not simply create new technology, but creates a scalable pathway for bringing quick, advanced infection diagnostics closer to patients.
NOTE: No VCCircle Journalist was involved in the creation of this content.
Published by HT Digital Content Services with permission from VC Circle.